Skip to main content
. 2016 Mar 17;7(16):22720–22732. doi: 10.18632/oncotarget.8150

Figure 3. CISD2 protein expression is associated with progression-free survival (PFS) in LSCC.

Figure 3

(A, B, C) Kaplan–Meier PFS survival curves in the training cohort (A), validation cohort (B) and the entire cohort (C) stratified by high and low expression of CISD2. P-values were calculated using the log-rank test.